Should I Buy MRM? MRM 2026 Analysis

Should You Buy Medirom Healthcare Technologies Inc (MRM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.330

1 Day change

-0.75%

52 Week Range

4.450

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: the trend is still decisively bearish and there are no proprietary buy signals to lean on.
Any upside from the extremely oversold RSI looks more like a short-lived bounce setup than a high-conviction entry.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), implying persistent downside pressure.
Momentum: MACD histogram at -0.0156 (below zero) and negatively contracting—bearish momentum still in place, though selling pressure may be easing.
Oscillators: RSI_6 at 6.768 = extremely oversold; this can precede a reflex bounce, but it does not by itself confirm a trend reversal.
Levels: Current price ~1.395 is below S1 (1.437) and near S2 (1.359). A breakdown below ~1.359 would be technically negative; recovery back above ~1.437 and then pivot ~1.563 would be needed to improve the setup.
Pattern-based forward bias: Similar-pattern stats suggest ~+0.99% next day but -2.06% next week and -2.71% next month (near-term bounce risk, medium-term drift lower).

Positive Catalysts

- Extremely oversold RSI increases probability of a short-term snapback.
- Premarket change is mildly positive (+0.68%), hinting at a potential near-term bounce attempt.
- Price is near a key support zone (S2 ~1.359), where buyers sometimes step in.

Neutral/Negative Catalysts

- Primary trend remains bearish (MA stack bearish; price below key levels).
- MACD remains negative, indicating the broader momentum backdrop is still weak.
- No news in the recent week: no clear event-driven catalyst to force a reversal.
- Trading trends: hedge funds neutral and insiders neutral (no supportive accumulation signal).
- Pattern-based outlook skews negative over the next week/month.

Financial Performance

Financial snapshot unavailable (data error: "list index out of range"), so latest quarter/season growth trends cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided, so Wall Street consensus pros/cons cannot be confirmed from this dataset.
With no visible analyst support data, the decision must rely mainly on weak technicals and the lack of catalysts.

Analyst Rating

Wall Street analysts forecast MRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRM is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.340

Low

Averages

High